When a student athlete wants to return to playing following a concussion, there are 6 phases that that athlete will need to follow to get pack to the field.
BLA resubmitted for lebrikizumab to treat AD patients 12 years and up
The resubmission was announced in a first quarter, 2024 earnings news release from Lilly, which expects "regulatory action in the second half of 2024."
Food Insecurity and the Dangers of Infant Formula Dilution
A deep dive into Qbtech's diagnostic ADHD test
A discussion based on an FDA-cleared objective ADHD diagnostic test developed by Qbtech.
Demystifying Infant Formula
FDA accepts sNDA for tapinarof cream, 1% to treat AD in children 2 years and up
A decision from the federal agency is expected in the fourth quarter of 2024.
FDA approves diazepam for seizure clusters in patients 2 to 5 years
With the approval comes the immediate availability of 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses for patients between 2 to 5 years of age.